📰 Lunit Scope News
Lunit Scope News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lunit Scope. Real-time updates on events, politics, business and more.
October 16, 2023
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the presentation of 9 studies at the upcoming European Society for Medical Oncology (ESMO) 2023 Congress, to be held in Madrid, Spain, from October 20-24.
August 30, 2023
On August 24, 2023, the National Labor Relations Board (the “Board”) issued a final rule (the “2023 final rule”) amending the federal regulations that govern representation election...
February 24, 2023
U.S. Court of Appeals for the D.C. Circuit partially reversed and partially upheld District Court decision that enjoined five rules promulgated by National Labor Relations Board in 2019 by the Trump-era Board to modify Board’s representation election procedures.
February 24, 2023
On January 17, 2023, the U.S. Court of Appeals for the D.C. Circuit partially reversed and partially upheld a District Court decision that enjoined five rules promulgated by the...
March 25, 2022
An AI-based test developed by South Korean biotech Lunit may improve identification of best responders to immunotherapy when used alongside PD-L1 testing.